C12N 2760/18543
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2760/18543 (Viral genome or elements thereof as genetic vector) appears on 32 US grants and 48 published applications in this corpus.
Search patents in C12N- Granted patents
- 32
- Published applications
- 48
- Assignees
- 30
- Inventors
- 105
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 4 |
| 2004 | 6 | 3 |
| 2005 | 2 | 8 |
| 2006 | 1 | 5 |
| 2007 | 1 | 3 |
| 2008 | 2 | 1 |
| 2009 | 2 | 3 |
| 2010 | 7 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Chimeric RSV and HMPV F proteins, immunogenic compositions, and methods of use10 Feb 2026US 12,544,436 B2Children's Healthcare of Atlanta, Inc.
- Respiratory syncytial virus expression vectors21 Apr 2020US 10,626,378 B2Children's Healthcare of Atlanta, Inc.
- Respiratory syncytial virus expression vectors12 Mar 2019US 10,227,569 B2Children's Healthcare of Atlanta, Inc.
- Recombinant RSV reporter virus16 Oct 2018US 10,100,372 B2Georgia State University Research Foundation, Inc.
- Lung cancer therapy using an engineered respiratory syncytial virus12 Jan 2016US 9,233,132 B2
- Modified Viral Genome Compositions and Methods of Production and Use Thereof4 Jun 2026US 2026/0152727 A1The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges
- Mutant of rsv f protein30 Apr 2026US 2026/0117202 A1National Vaccine and Serum Institute(Nvsi)
- Pan-pneumovirus vaccine compositions and methods of use thereof22 May 2025US 2025/0161429 A1University of Georgia Research Foundation, Inc.
- Immunogenic compositions and uses thereof1 Aug 2024US 2024/0252612 A1Pfizer Inc.
- Respiratory virus immunizing compositions26 Oct 2023US 2023/0338506 A1ModernaTX, Inc.
Most cited
By later US patents
- Prevention and treatment of respiratory tract disease115US 5,716,821 AThe UAB Research Foundation · 1998
- Stranded RNA virus particles108US 5,789,229 AThe UAB Research Foundation · 1998
- Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins51US 6,790,449 B2The United States of America as represented by the Department of Health and Human Services · 2004
- Product of infectious respiratory syncytial virus from cloned nucleotide sequences37US 6,264,957 B1The United States of America as represented by the Department of Health and Human Services · 2001
- Attenuated chimeric respiratory syncytial virus31US 7,846,455 B2The United States of America as represented by the Department of Health and Human Services · 2010